Matches in SemOpenAlex for { <https://semopenalex.org/work/W2269161696> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2269161696 endingPage "8" @default.
- W2269161696 startingPage "853" @default.
- W2269161696 abstract "Mexiletine, lidocaine, and tocainide are class IB antiarrhythmic drugs that are used for the treatment of ventricular arrhythmias and are known to inhibit drug metabolism. The objectives of this study were to characterize the inhibitory effects of mexiletine, lidocaine, and tocainide on cytochrome P-450 1A2 (CYP1A2) activity in human liver microsomes and to evaluate their relative inhibitory potencies by using a molecular model of this P-450 isozyme. The inhibitory effect of mexiletine, lidocaine, and tocainide on cytochrome CYP1A2 in human liver microsomes was examined with methoxyresorufin O-demethylase activity as an index of the catalytic activity of this P-450 isozyme. The kinetic inhibition types and Ki values were determined by Lineweaver-Burk plots and Dixon plots, respectively. Molecular modeling was used to assess the interaction of these agents with the CYP1A2 active site. Methoxyresorufin O-demethylase activity was inhibited 67 +/- 8%, 20 +/- 5%, and 7 +/- 4% by 2 mM mexiletine, lidocaine, and tocainide, respectively. Mexiletine and lidocaine exhibited competitive inhibition with Ki values of 0.28 +/- 0.12 mM and 1.54 +/- 0.74 mM, respectively, whereas the inhibition type of tocainide could not be determined because of its weak potency. A charge interaction between mexiletine and the Asp313 side chain in the CYP1A2 active site was found, and varying degrees of hydrogen bond formation between these three compounds and the CYP1A2 active site were observed. The in vitro inhibitory potencies in human liver microsomes (mexiletine > lidocaine > tocainide) are consistent with the structural interactions found in a molecular model of the active site of CYP1A2." @default.
- W2269161696 created "2016-06-24" @default.
- W2269161696 creator A5004489015 @default.
- W2269161696 creator A5065053109 @default.
- W2269161696 creator A5070096340 @default.
- W2269161696 creator A5079036179 @default.
- W2269161696 creator A5083506223 @default.
- W2269161696 creator A5085749114 @default.
- W2269161696 date "1999-05-01" @default.
- W2269161696 modified "2023-10-18" @default.
- W2269161696 title "Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide." @default.
- W2269161696 cites W1520746198 @default.
- W2269161696 cites W1775749144 @default.
- W2269161696 cites W1852941485 @default.
- W2269161696 cites W1965092741 @default.
- W2269161696 cites W2004158925 @default.
- W2269161696 cites W2017729229 @default.
- W2269161696 cites W2027343163 @default.
- W2269161696 cites W2031101878 @default.
- W2269161696 cites W2032390903 @default.
- W2269161696 cites W2036701227 @default.
- W2269161696 cites W2039008850 @default.
- W2269161696 cites W2046562833 @default.
- W2269161696 cites W2049890602 @default.
- W2269161696 cites W2081395866 @default.
- W2269161696 cites W2100837269 @default.
- W2269161696 cites W2101108802 @default.
- W2269161696 cites W2311342455 @default.
- W2269161696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10215663" @default.
- W2269161696 hasPublicationYear "1999" @default.
- W2269161696 type Work @default.
- W2269161696 sameAs 2269161696 @default.
- W2269161696 citedByCount "5" @default.
- W2269161696 countsByYear W22691616962015 @default.
- W2269161696 crossrefType "journal-article" @default.
- W2269161696 hasAuthorship W2269161696A5004489015 @default.
- W2269161696 hasAuthorship W2269161696A5065053109 @default.
- W2269161696 hasAuthorship W2269161696A5070096340 @default.
- W2269161696 hasAuthorship W2269161696A5079036179 @default.
- W2269161696 hasAuthorship W2269161696A5083506223 @default.
- W2269161696 hasAuthorship W2269161696A5085749114 @default.
- W2269161696 hasConcept C112705442 @default.
- W2269161696 hasConcept C185592680 @default.
- W2269161696 hasConcept C202751555 @default.
- W2269161696 hasConcept C2777561782 @default.
- W2269161696 hasConcept C2780149897 @default.
- W2269161696 hasConcept C42219234 @default.
- W2269161696 hasConcept C55493867 @default.
- W2269161696 hasConcept C71924100 @default.
- W2269161696 hasConcept C86745063 @default.
- W2269161696 hasConcept C87644729 @default.
- W2269161696 hasConcept C97320921 @default.
- W2269161696 hasConcept C98274493 @default.
- W2269161696 hasConceptScore W2269161696C112705442 @default.
- W2269161696 hasConceptScore W2269161696C185592680 @default.
- W2269161696 hasConceptScore W2269161696C202751555 @default.
- W2269161696 hasConceptScore W2269161696C2777561782 @default.
- W2269161696 hasConceptScore W2269161696C2780149897 @default.
- W2269161696 hasConceptScore W2269161696C42219234 @default.
- W2269161696 hasConceptScore W2269161696C55493867 @default.
- W2269161696 hasConceptScore W2269161696C71924100 @default.
- W2269161696 hasConceptScore W2269161696C86745063 @default.
- W2269161696 hasConceptScore W2269161696C87644729 @default.
- W2269161696 hasConceptScore W2269161696C97320921 @default.
- W2269161696 hasConceptScore W2269161696C98274493 @default.
- W2269161696 hasIssue "2" @default.
- W2269161696 hasLocation W22691616961 @default.
- W2269161696 hasOpenAccess W2269161696 @default.
- W2269161696 hasPrimaryLocation W22691616961 @default.
- W2269161696 hasRelatedWork W1572982815 @default.
- W2269161696 hasRelatedWork W1977246230 @default.
- W2269161696 hasRelatedWork W2042629607 @default.
- W2269161696 hasRelatedWork W2047993460 @default.
- W2269161696 hasRelatedWork W2065185424 @default.
- W2269161696 hasRelatedWork W2067772266 @default.
- W2269161696 hasRelatedWork W2269161696 @default.
- W2269161696 hasRelatedWork W2311342455 @default.
- W2269161696 hasRelatedWork W3180570082 @default.
- W2269161696 hasRelatedWork W3215806176 @default.
- W2269161696 hasVolume "289" @default.
- W2269161696 isParatext "false" @default.
- W2269161696 isRetracted "false" @default.
- W2269161696 magId "2269161696" @default.
- W2269161696 workType "article" @default.